Norway Syndromic Multiplex Diagnostic Market to 2032
Overview
The Norway Syndromic Multiplex Diagnostic Market is expected to reach a 33.04 USD Million by 2032 and is projected to grow at a CAGR of 6.82% from 2025 to 2032.
Revenue, 2024 (USD Million)
19.56
Forecast, 2032 (USD Million)
33.04
CAGR, 2024 - 2032
6.82%
Report Coverage
Norway
Norway Syndromic Multiplex Diagnostic Market 2018-2032 USD Million
Norway Syndromic Multiplex Diagnostic Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 19.56 USD Million
- Projected Market Size (2032): 33.04 USD Million
- CAGR (2025-2032): 6.82%
Key Findings of Norway Syndromic Multiplex Diagnostic Market
- The Norway Syndromic Multiplex Diagnostic Market was valued at 19.56 USD Million in 2024.
- The Norway Syndromic Multiplex Diagnostic Market is likely to grow at a CAGR of 6.82% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Direct Tender in Distribution Channel Segment accounted for the largest share of the market with a revenue of 13.90 USD Million
- The fastest growing segment Respiratory Infections in Disease Segment grew Fastest with a CAGR of 7.89% during the forecast period from 2024 to 2032.
Norway Syndromic Multiplex Diagnostic Market Scope
Norway Syndromic Multiplex Diagnostic Market Segmentation & Scope
Product Type
- Software & Services
- Instruments
- Accessories & Consumables
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Infection Type
- Others
- Parasites
- Fungal
- Bacterial
- Viral
End User
- Research Institutes
- Others
- Pharmaceutical & Biotechnology Companies
- Physician Offices
- Clinical Laboratories
- Hospitals
Disease
- Eye Infections
- Hepatitis
- Tropical Fever
- Immunosuppression
- Other Diseases
- Childhood Infections
- Meningitis
- Sexually Transmitted Infections
- Gastroenteritis
- Respiratory Infections
Norway Syndromic Multiplex Diagnostic Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2024 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 19.56 USD Million |
| Market Value in 2032 | 33.04 USD Million |
| CAGR (2025-2032) | 6.82% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Product Type,Distribution Channel,Infection Type,End User,Disease |
Regional Insights:
-
Leading Market (2024-2032): Norway, leading in terms of revenue 19.56 USD Million in 2024
- Key Country: Norway, leading in terms of revenue with value of 19.56 USD Million in 2024.
Segments and Scope
-
Norway Syndromic Multiplex Diagnostic Market to 2032, By Product Type
- Accessories & Consumables is the largest segment in Norway Syndromic Multiplex Diagnostic Market to 2032 with a revenue of 12.44 USD Million in the year 2024.
- Accessories & Consumables is the Fastest growing segment in Norway Syndromic Multiplex Diagnostic Market to 2032 with a Growth rate of 7.10 % in forecast period 2025-2032.
-
Norway Syndromic Multiplex Diagnostic Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Norway Syndromic Multiplex Diagnostic Market to 2032 with a revenue of 13.90 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Norway Syndromic Multiplex Diagnostic Market to 2032 with a Growth rate of 6.96 % in forecast period 2025-2032.
-
Norway Syndromic Multiplex Diagnostic Market to 2032, By Infection Type
- Viral is the largest segment in Norway Syndromic Multiplex Diagnostic Market to 2032 with a revenue of 9.41 USD Million in the year 2024.
- Viral is the Fastest growing segment in Norway Syndromic Multiplex Diagnostic Market to 2032 with a Growth rate of 7.08 % in forecast period 2025-2032.
-
Norway Syndromic Multiplex Diagnostic Market to 2032, By End User
- Hospitals is the largest segment in Norway Syndromic Multiplex Diagnostic Market to 2032 with a revenue of 9.07 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Norway Syndromic Multiplex Diagnostic Market to 2032 with a Growth rate of 7.21 % in forecast period 2025-2032.
-
Norway Syndromic Multiplex Diagnostic Market to 2032, By Disease
- Respiratory Infections is the largest segment in Norway Syndromic Multiplex Diagnostic Market to 2032 with a revenue of 6.91 USD Million in the year 2024.
- Respiratory Infections is the Fastest growing segment in Norway Syndromic Multiplex Diagnostic Market to 2032 with a Growth rate of 7.89 % in forecast period 2025-2032.
Norway Syndromic Multiplex Diagnostic Market Company Share Analysis
| Company Name |
|
||
| Thermo Fisher Scientific Inc. | |||
| QIAGEN | |||
| BIOMÉRIEUX | |||
| DiaSorin S.p.A | |||
| F. Hoffmann-La Roche Ltd. | |||
Norway Syndromic Multiplex Diagnostic Market Geographical Sales Distribution, 2018-2032 USD Million
Norway Syndromic Multiplex Diagnostic Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Norway Syndromic Multiplex Diagnostic Market is segmented based on Segmentation Product Type,Distribution Channel,Infection Type,End User,Disease.
Norway Syndromic Multiplex Diagnostic Market was valued at USD 19.56(Revenue in USD Million) in 2024.
Norway Syndromic Multiplex Diagnostic Market is projected to grow at a CAGR of 6.82% during the forecast period of 2024 to 2032.
The Direct Tender segment is expected to dominate the Norway Syndromic Multiplex Diagnostic Market, holding a largest market share of 13.90 USD Million in 2024
Norway Syndromic Multiplex Diagnostic Market Scope
Norway Syndromic Multiplex Diagnostic Market Segmentation & Scope
Product Type
- Software & Services
- Instruments
- Accessories & Consumables
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Infection Type
- Others
- Parasites
- Fungal
- Bacterial
- Viral
End User
- Research Institutes
- Others
- Pharmaceutical & Biotechnology Companies
- Physician Offices
- Clinical Laboratories
- Hospitals
Disease
- Eye Infections
- Hepatitis
- Tropical Fever
- Immunosuppression
- Other Diseases
- Childhood Infections
- Meningitis
- Sexually Transmitted Infections
- Gastroenteritis
- Respiratory Infections
Frequently Asked Questions
The Norway Syndromic Multiplex Diagnostic Market is segmented based on Segmentation Product Type,Distribution Channel,Infection Type,End User,Disease.
Norway Syndromic Multiplex Diagnostic Market was valued at USD 19.56(Revenue in USD Million) in 2024.
Norway Syndromic Multiplex Diagnostic Market is projected to grow at a CAGR of 6.82% during the forecast period of 2024 to 2032.
The estimated market value of the Norway Syndromic Multiplex Diagnostic Market for final year is USD 33.04 (USD Million).
Norway Syndromic Multiplex Diagnostic Market Company Profiling
Frequently Asked Questions
The Norway Syndromic Multiplex Diagnostic Market is segmented based on Segmentation Product Type,Distribution Channel,Infection Type,End User,Disease.
Norway Syndromic Multiplex Diagnostic Market was valued at USD 19.56(Revenue in USD Million) in 2024.
Norway Syndromic Multiplex Diagnostic Market is projected to grow at a CAGR of 6.82% during the forecast period of 2024 to 2032.
The estimated market value of the Norway Syndromic Multiplex Diagnostic Market for final year is USD 33.04 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.